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Summary: This paper describes a fully automated assay on the Serono SRI™ for the measurement of cortisol
in serum, heparinised plasma and urine. The assay incorporates a specific polyclonal antibody to cortisol and
cortisol conjugated to alkaline phosphatase as a label. Following immunoincubation, bound and free labelled
cortisol are separated by magnetic sedimentation of the antibody complex. Phenolphthalein is liberated by
the enzymatic hydrolysis of the substrate (phenolphthalein monophosphate) and the absorbance generated is
measured as the assay end-point. All processing steps are performed by the SRI.
The assay has good analytical performance with respect to precision (within and between run CVs less than
10 and 11.5% respectively), detection limit (less than 5 nmol/1) and recovery of added cortisol (100 ± 10%).
The assay agrees well with cortisol concentrations determined by ID-MS and by established immunoassays
(r > 0.96). Reference ranges of normal urine samples (pretreated by solvent extraction) are in good agreement
with accepted values.
The study demonstrates that the SRI Cortisol assay on the SRI analyzer is suitable for the routine
determination of cortisol in serum, heparinised plasma and urine samples.
Introduction ,^ .
 x , , · ι _ . ι _ r r* r 11This study describes the performance of a fully au-
The measurement of serum cortisol is useful in the tomated enzyme immunoassay for cortisol using the
evaluation of both adrenal and pituitary function and SRI™ analyzer (Serono Diagnostics) with reference
in the differentiation of the pathological conditions to its suitability for routine use in a clinical chemistry
associated with dysfunction of the pituitary-adrenal laboratory,
axis (1). Urinary cortisol provides high diagnostic
sensitivity for hypercorticoidism (2). Immunoassays
for the determination of urinary cortisol tend to omit Materials and Methods
Chromatographie purification Steps, SO that cortisol Assay specific reagents were provided by Serono Diagnostics
metabolites contribute to the analytical value. In view s·A·» Coinsins, Switzerland.
of the lack of Specificity of these methods, sample Human serum was collected from donors (n = 200) at a blood
pretreatment is recommended (3). transfusion clinic. Urine samples were collected from normal,
ambulatory individuals (n = 29). Serum and plasma samples
Various manual and semi-automated immunoassay were also collected from the routine workload of two chemical
t , , , , ·ι_ j r ^ χ r pathology laboratories (n = 105). All samples were stored at
methods have been described for the measurement of 120 oc^ntil they were Assayed.
cortisol; these include radioimmunoassay (4), chemi-
. /zr\ j η ι · „.· ff\ - Commercial control sera (Lyphochek ECS Controls 1,2 and 3luminescence (5) and fluorescence polarization (6) im-
 Lot No 60000) were purchased from BioRad Laboratories,
munoassay. Very recently, the first report of an au- Herts, UK.
tomated immunoassay for cortisol has appeared in cortisol-free human serum (Code 3SH015) was purchased from
the literature (7). Scantibodies, San Diego, USA.
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Pure cortisol (USP grade) was purchased from the United States
Pharmacopeial Convention, Maryland, USA.
All potential cross-reactants (tab. 2) were purchased from
Sigma, Dorset, UK.
BCR Control Material (RM192/193) was supplied as reference
sera by the Community Bureau of Reference (Commission of
the European Communities) (8).
Commercial immunoassay kits were obtained from:
Diagnostic Products Corporation (DPC), Los Angeles, Cali-
fornia, USA
Amerlite Diagnostics Limited, Amersham, UK
Boehringer Mannheim GmbH Diagnostica, Tutzing, Germany
Abbott Diagnostics Division, Chicago, Illinois, USA
Analyt ical procedure
All cortisol determinations were performed using the SRI Cor-
tisol assay on the SRI™ analyzer (Serono Diagnostics). The
SRI Cortisol assay uses a rabbit anti-cortisol polyclonal anti-
serum in an enzyme immunoassay. Fluorescein-conjugated an-
tibody and a cortisol derivative conjugated to calf intestinal
alkaline phosphatase (EC 3.1.3.1) are added to samples or
standards. The reactants are incubated at 37 °C for 12 minutes.
During the incubation, cortisol in the sample or standard (50
μΐ) competes with the enzyme-labelled cortisol derivative (150
μΐ) for binding to the fluorescein-labelled antibody (150 μΐ). At
the end of this incubation, anti-fluorescein coupled to a mag-
netic solid phase is added (200 μΐ). This rapidly (6 minutes
incubation) binds to the antibody complex and is sedimented
in a magnetic field. After aspiration of the liquid and washing
of the solid phase, a solution of the enzyme substrate (phen-
olphthalein monophosphate) is added and the mixture incu-
bated at 37 °C for 12 minutes. At the end of this period the
reaction is stopped by the addition of sodium hydroxide (final
pH = 10.6) and the intensity of the colour developed is meas-
ured photometrically. The intensity of the colour developed is
inversely proportional to the concentration of cortisol in the
sample or standard. The concentration of cortisol is calculated
from a stored standard curve. The time to first result is 46
minutes; 59 samples can be processed in 120 minutes.
Precision
Within assay precision was determined by replication (n = 20)
of three levels of control sera. To assess between assay precision,
three levels of control sera were assayed in duplicate on ten
occasions over a period of one month using 2 lots of reagents
(n = 20).
Recovery and accuracy
The recovery of the assay was determined by adding pure
cortisol at different levels to 5 serum pools with low endogenous
levels of cortisol. Recovery of added cortisol was calculated as
recommended by the ECCLS guidelines (9).
Accuracy was determined by assaying the BCR material on 6
occasions. This material is supplied with cortisol concentrations
assigned by isotope dilution—mass spectrometry (ID-MS).
Specificity
The specificity of the assay was determined by measuring Ihe
apparent response to various potentially cross-reacting sub-
stances. Cross-reactivity was calculated as:
Cross-reactivity (%)
Apparent cortisol dose (nmol/1)
Added dose cross-reactant (nmol/1) χ 100
Dilution
Accuracy was also monitored by assaying ten patient pools
diluted with human cortisol-free serum.
Expected values
Reference ranges for normal subjects were established using
data from serum (n = 200) and urine (n = 29) samples col-
lected from healthy blood donors. Matched serum samples
(n = 36) were also collected at 09.00 hours and midnight from
healthy volunteers. Reference ranges were calculated as 2.5 and
97.5 percentiles.
Correlation with other immunoassays
The SRI Cortisol assay was compared with the following as-
says:
Diagnostic Products Corporation, Coat-a-Count (radioimmu-
noassay).
Amerlite Diagnostics Limited, Amerlite (luminescence-en-
hanced enzyme immunoassay).
Abbott Diagnostics, TDx (fluorescence polarization immu-
noassay).
Boehringer Mannheim, Enzymun-Test (enzyme immunoassay).
Regression lines were calculated using the method of Passing
& Bablok (10).
Application to urine
Urine samples were collected without preservative as 24 hour
collections. Urinary cortisol values were determined with and
without prior sample pretreatment. Briefly, the pretreatment
was performed as follows: 500 μΐ of freshly collected urine were
extracted in 2.5 ml of ice-cold dichloromethane. Following
removal of the solvent by evaporation, the extract was recon-
stituted in human cortisol-free serum and assayed as a serum
sample. The precision and accuracy of the method was similar
to that of the serum assay. The average recovery of this method
was 96.5 ± 11.9%. This was assessed by addition of pure
cortisol to urine, followed by extraction and calculation of the
recovery as recommended (8).
Results
Precision
Within and between assay precision are summarised
in table 1.
Detection limit
The detection limit of the assay was defined as the concentration
of cortisol equivalent to the mean absorbance of the zero
standard minus two standard deviations calculated from 20
replicates of the zero analyte standard.
Detection limit
The detection limit of the assay determined on four
occasions was typically less than 5 nmol/1 (mean
= 2.7 nmol/1, range = 1.9 to 3.3 nmol/1).
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Tab. 1 . Within and between assay precision using control sera
M can (nmol/1) S. D.
Within-assay precision (n = 20)
8'9.2 8.6
548 47.5
863 82.5
Between-assay precision (n = 20)
&7.6 10.1
553 45.4
941 79.0
Tab. 2. Assay specificity
Cross reactant
Prednisone
Prednisolone
6- Methylprednisolone
1 1 -Deoxycortisol
Corticosterone
Cortisone
1 1 -Deoxycorticosterone
17-a Hydroxyprogesterone
Dexamethasone
Oestradiol
Oestrone
Oestriol
Progesterone
Testerone
Aldosterone
Spironolactone
Canrenone
CV (%)
9.7
8.6
9.6
11.5
8.2
8.4
Cross-reaction (%)
0.9
40.1
4.1
5.6
1.3
1.4
2.3
3.4
8.4
<0.2
<0.2
<0.2
1.5
1.3
5.9
<0.2
<0.2
Specificity
Specificity is summarized in table 2. Only the phar-
maceutical drug prednisolone was found to cross-
react significantly.
Tab. 3. Assay characteristics
a) Recovery of exogenous cortisol
Cortisol Number of
added samples
(nmol/1)
107 5
217 5
495 5
977 5
Overall 20
b) Dilution characteristics
Dilution Number of
factor samples
1 in 2 10
1 in 4 10
1 in 8 10
Overall 30
c) Normal reference ranges
Group Time of
sampling
Normal females Random
Normal males Random
Normal adults 09.00
Normal adults Midnight
Pregnant
3rd trimester Random
Group Time of Number
sampling in study
Normal 24 hour 29
adults
Mean
recovery
(%)
102.6
92.6
102.9
108.0
101.5
% of undil-
uted value
99.4
101.2
108.0
102.9
Number
in study
100
100
36
36
25
SD
5.3
4.2
8.4
12.5
9.5
SD
5.0
8.2
10.6
8.8
Cortisol
in serum
(nmol/1)
97-356
106-493
134-589
8-221
276-739
Cortisol in urine
Extract-
ion pro-
cedure
(nmol/
24 hours)
35-253
Un-
extracted
urine
(nmol/
24 hours)
250-2481
Recovery is summarised in table 3(a). The overall
recovery of added cortisol was 101.5 ±9.5%.
The BCR control sera were assigned the following
values:
Control ID-MS SRI value
target value (Mean ±2.5 SD)
(nmol/1) (nmol/1)
RM 192 273 227 ± 53.2
RM 193 763 709 ± 128
Dilution
Dilution is summarised in table 3(b). The assay shows
good linearity over the dilution range investigated.
Expected values
Table 3(c) shows reference ranges for normal subjects
using the SRI Cortisol assay. These ranges are in-
tended only as a guide and may vary depending on
the population studied. They are in good agreement
with previously published reference ranges (1). Unex-
tracted urine samples give higher cortisol concentra-
tions than the corresponding extracted samples.
Correlation with other immunoassays
Figure 1 shows comparisons of cortisol results using
four different immunoassays. In general, a good cor-
relation was obtained between SRI Cortisol and the
other products.
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Fig. 1. Correlation of SRI Cortisol values with
a) enzyme immunoassay, (b) enhanced chemiluminescent immunoassay, (c) radioimmunoassay and (d) fluorescence
polarization immunoassay
a) y = 0.992x - 100.65; n = 85
b) y = 0.809x - 96.62; n = 87
c) y = 0.954x - 71.57; n = 80
d) y = 0.844x - 40.56; n = 95
Conclusion
This paper describes the performance of a fully au-
tomated enzyme immunoassay for the measurement
of cortisol in serum, heparinised plasma and urine.
The range (5 — 1656 nmol/l) and detection limit
(< 5 nmol/l) of the assay make it suitable for all
clinical applications of the assay. The assay has good
specificity for cortisol. Only prednisolone (a thera-
peutic drug with marked structural similarity to cor-
tisol) shows a significant cross-reaction. Samples from
patients taking prednisolone are therefore contra-in-
dicated. The concentrations of cortisol measured with
this assay show good agreement with values measured
with other immunoassays and by isotope dilution-
mass spectrometry. Urine samples should be extracted
prior to assay, because the method co-measures cor-
tisol metabolites in urine.
In conclusion, the SRI Cortisol assay on the SRI
analyzer fulfills all the necessary criteria for routine
clinical analysis. The SRI provides walk-to, walk-
away automation, random access and batch modes
of operation and uses stored standard curve calibra-
tion. The time to first result for a cortisol assay is 46
minutes and thereafter two results every two minutes.
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